Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - PTC THERAPEUTICS, INC. | ex992agilisriskfactors-exh.htm |
| EX-99.4 - EXHIBIT 99.4 - PTC THERAPEUTICS, INC. | ex994proforma.htm |
| EX-99.3 - EXHIBIT 99.3 - PTC THERAPEUTICS, INC. | form8-ka082418xexhibit992.htm |
| EX-99.1 - EXHIBIT 99.1 - PTC THERAPEUTICS, INC. | ex991ptcpressrelease082318.htm |
| 8-K - 8-K 08.24.18 - PTC THERAPEUTICS, INC. | form8-k082418.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT AUDITORS
PTC Therapeutics, Inc.
South Plainfield, New Jersey
We hereby consent to the incorporation by reference in the Registration Statements on Form S3 (No. 333-220151) and Form S-8 (No. 333-194323, 333-189962, 333-203485, 333-208830, 333-211997, 333-215407, and 333-222391) of PTC Therapeutics, Inc. of our report dated August 21, 2018, relating to the consolidated financial statements, which appears in this Current Report on Form 8-K dated August 24, 2018.
/s/ BDO USA, LLP
Boston, Massachusetts
August 24, 2018